Three new muramyl peptides (muraceins A, B and C) have been isolated from fermentations of Nocardia orientalis as inhibitors of angiotensin-converting enzyme (ACE). Structures 1 and 2, for muraceins A and B respectively, were deduced from their spectroscopic properties. Muracein C, 3, was shown to be a muramyl pentapeptide containing N-acetylmuramic acid, alanine, glutamic acid, serine and diaminopimelic acid in a 1:2: 1: 1 : 1 ratio based on the 'H NMR integration .
Three new muramyl peptides (muraceins A, B and C) have been isolated from fermentations of Nocardia orientalis as inhibitors of angiotensin-converting enzyme (ACE). Structures 1 and 2, for muraceins A and B respectively, were deduced from their spectroscopic properties. Muracein C, 3, was shown to be a muramyl pentapeptide containing N-acetylmuramic acid, alanine, glutamic acid, serine and diaminopimelic acid in a 1:2: 1: 1 : 1 ratio based on the 'H NMR integration .
During the course of a screening program directed toward the isolation and evaluation of angiotensin-converting enzyme (ACE) inhibitors of microbial origin, three new N-acetylmuramyl peptides manifesting a specific inhibitory action against ACE were found in the culture broth of Nocardia orientalis SC 12,482 (ATCC 39444). Biological and taxonomic studies on the strain ATCC 39444
were presented in the preceding paper". In this paper we describe the isolation and structure elucida- a TLC on silica gel using EtOAc -BuOHAcOH -MO, 1: 1: 1: 1, Rydon-visualization. '' HPLC using C18 spherical packed column (8 mm x 10 cm, 10 ,um) with Waters Z-module; 10% CH3CN, 0.1% 1-heptanesulfonic acid sodium salt in water, isocratic, pH 2.1 with HCI; 1.5 ml/minute; 210 ran. tion of two muramyl peptides, muracein A (1, I50=0.18 Icg/ml), muracein B (2, I60=145 pg/ml) and characterization of a third muramyl peptide, muracein C (3, IJ0=9.8 pg/ml) ( Fig. 1 ).
Isolation Procedure
The extraction and purification procedure is outlined in Fig. 2 . The ACE inhibitory activity was measured spectrophotometrically using captopril as a positive standard, p-nitrobenzyloxycarbonyl-
) as a chromogenic substrate and partially purified rabbit lung ACE. The activity which was found in the broth supernate, was adsorbed on a column of Darco granular charcoal, eluted with Me_CO -H2O (1: 1), and further purified by ion-exchange chromatography on Bio-Rad AGI-X2, OAc-. The separation of muraceins A, B and C was accomplished by reversedphase chromatography on MCI gel CHP20P eluting with water followed by a 0-66% Me2CO -H2O gradient. The fractions containing muraceins A and C eluted with water; these were combined on the basis of TLC (silica gel, EtOAc -BuOH -AcOH -H2O, 1: 1: 1 : 1, Rydon visualization) and HPLC analysis (Table 1) . Muracein B eluted with -54% Me2CO -H2O. Experimental NMR spectra were determined on Varian Associates model XL-100-15 and Joel Ltd. GX 400 spectrometers. Infrared spectra were recorded on a Perkin-Elmer model 621 spectrometer. Rotations were measured on a Perkin-Elmer model 141 polarimeter. Mass spectra were determined on a VG Analytical Ltd. model ZAB 1F spectrometer. GC-MS measurements were done on an Extranuclear Laboratories modified Simulscan instrument. The configurations of amino acids were determined either by GC using a chiral column (Altech Associates 25 m glass WCOT column with RSL-007 stationary phase) or by HPLC using a Waters C18-,uBondapak column in a Waters Z-module.
Isolation of Muraceins A, B and C At harvest, the cells from a 20-liter fermentation of N. orientalis ATCC 39444 were separated by centrifugation. The broth supernate (19 liters, pH 3.0), was passed through a column of Darco granular charcoal (5 45 cm). The column was washed with water (3 liters) and the active principle eluted with 50%. aqueous acetone (4 liters). The active fractions were combined and concentrated in vacuo to give a yellow solid (9.97 g). A solution of the solid in water (10 ml) was adjusted to pH 9.0 with 5 M NaOH and then purified by anion-exchange chromatography on Bio-Rad AGl-X2, OAc-, 200-400 mesh (5,x 30 cm). The column was washed with 600 ml of water and then eluted with a linear gradient of 0 -0.25 M pyridine -AcOH, pH 5.1 (6 liters). The active fractions were combined and concentrated in vacuo to give a mixture of muraceins A, B and C as a yellow solid (1.2 g).
The mixture was dissolved in water (1 ml, pH 3.5) and applied to a column of MCI gel CHP20P (2.5 x 54 cm). The column was eluted with water (600 ml) followed by a 0-66 % Me2CO -1120 gradient (600 ml, collecting 8 ml fractions). The most active component eluted with water and the fractions were combined on the basis of TLC and HPLC analysis (Table 1) . Fractions 4474, which contained muracein A by TLC and HPLC analysis, were combined and concentrated in vacuo to give 121 mg of muracein A (monosodium salt, Ibo=0.18 ,ug/ml) as a white powder. 13C NMR (D20) 6 18-23 (C-15, C-18, C-20), 22, 29-30(C-3, C-4, C-5, C-9, C-10), 50-57 (C-2, C-6, C-11, C-14, C-2'), 
